IMA compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

IMAImageneBio, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

IMAImageneBio, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

IMAImageneBio, Inc.

4.10· pre 4.10· delayed

Mkt cap$46.5MRevenue$800,000Q4 FY25Revenue—

AMGNAmgen Inc

460.67· pre 474.00· delayed

Pre-marketNov 4 '26delayed

Mkt cap$249.4BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Pre-marketNov 4 '26delayed

IMAImageneBio, Inc.

AMGNAmgen Inc

4.10pre 4.10delayed

Price

460.67pre 474.00delayed

$46.5M

Mkt cap

$249.4B

Q4 FY25$800,000

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

IMA4.10vsAMGN460.67Pre-marketNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

IMA, solidAMGN, dashed

Supply-chain overlap

Revenue flow

IMA: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IMA 3

—Hutchmedunlistedsupplier

—Wuxi Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›